BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 30

• FDA

  Abdera Therapeutics Announces FDA Fast Track Designation for ABD-147, a Next-Generation Precision Radiopharmaceutical Therapy, for the Treatment of Patients with Extensive-stage Small Cell Lung Cancer

  Abdera Therapeutics Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to ABD-147 for the treatment of patients with extensive stage small cell lung cancer (ES-SCLC) who have progressed on or after platinum-based chemotherapy.

  June 27, 2024

   · 

  4 min read
• Biotech Beach

  Holoclara Announces $16 Million Series A Financing to Advance a Breakthrough Class of Worm-Derived Therapies for Allergic and Autoimmune Disease

  Holoclara today announced the completion of an oversubscribed $16 million Series A financing led by BOLD Capital Partners.

  June 27, 2024

   · 

  4 min read
• Business

  Komodo Health Appoints Julia Goebel as Chief Marketing Officer

  Healthcare technology company Komodo Health today announced the appointment of Julia Goebel as Chief Marketing Officer (CMO).

  June 27, 2024

   · 

  3 min read
• Biotech Bay

  EditCo Bio, Inc. Expands Primary Cell Portfolio with Launch of Knockout CD8+ T-cell Pools

  EditCo Bio, Inc., a leader in genome engineering innovation, announced the expansion of its T-cell editing portfolio with the launch of Knockout CD8+ T-cell Pools.

  June 27, 2024

   · 

  2 min read
• Biotech Beach

  Ensysce Biosciences Discusses Key Themes from the EPHMRA 2024 Annual Meeting

  Ensysce Biosciences, Inc. provides takeaways from Geoff Birkett, the Company’s Chief Commercial Officer, following his participation on the opening panel of the European Pharmaceutical Market Research Association (EPHMRA) Annual Conference in London on June 25.

  June 27, 2024

   · 

  5 min read
• BioForest

  RareCyte secures $20M financing to expand the Orion™ Spatial Biology platform including Multiplex Assay Reagents, Software and Precision Biology Services

  RareCyte, Inc. announced today the completion of a $20M financing from new and existing investors.

  June 27, 2024

   · 

  2 min read
• Genetown

  Akebia Therapeutics to Present at the H.C. Wainwright 3rd Annual Kidney Virtual Conference

  Akebia Therapeutics today announced that John Butler , Chief Executive Officer, will participate in the H.C. Wainwright 3rd Annual Kidney Virtual Conference on Monday, July 15, 2024.

  June 27, 2024

   · 

  1 min read
• Business

  Immunome Appoints Phil Tsai as Chief Technical Officer

  Immunome, Inc. today announced the appointment of Phil Tsai, PhD, as Chief Technical Officer.

  June 27, 2024

   · 

  5 min read
• Business

  Biotricity Reports Strong Results with Revenue Growth, Continued Margin Improvement, and Reduced Operating Expenses for Fiscal Year 2024, Accelerating the Company’s Path to Profitability

  Biotricity Inc. today announced its financial results for the fourth quarter and fiscal year ended March 31, 2024.

  June 27, 2024

   · 

  7 min read
• Business

  Intelligent Bio Solutions Expands Presence in the UK Retail Sector with Major Account Acquisitions

  Intelligent Bio Solutions Inc. today announced the expansion of its customer network within the UK retail sector.

  June 27, 2024

   · 

  4 min read